Related Experiment Video
Updated: Jul 25, 2025

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
In vivo variable and multi-day response from an insulin-releasing photoactivated depot
Karthik Nadendla1, Swetha Chintala1, Karen Kover2
1Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108, United States.
Researchers demonstrated dose-dependent and multi-day release of insulin using a photoactivated depot (PAD) system. This light-controlled insulin delivery shows potential for managing blood glucose levels in diabetes.
Area of Science:
- Biomedical Engineering
- Drug Delivery Systems
- Endocrinology
Background:
- Photoactivated depot (PAD) technology enables light-controlled therapeutic peptide release.
- Previous studies showed light-induced insulin release and blood glucose reduction in diabetic animals.
Purpose of the Study:
- To demonstrate dose-response for light-controlled insulin release from a PAD.
- To show multi-day insulin release from a single PAD injection.
- To support the utility of PAD for variable and extended therapeutic peptide delivery.
Main Methods:
- Utilized CD-insulin, a modified insulin with reduced solubility forming a depot upon injection.
- Administered varying amounts of light to irradiate the PAD.
- Monitored insulin release and blood glucose levels in diabetic animal models.
Main Results:
- Demonstrated a dose-response relationship between light administered and insulin release/blood glucose reduction.
- Achieved multi-day insulin release from the same depot on separate days.
- Confirmed photolysis of the cyclododecyl group, releasing soluble insulin.
Conclusions:
- The photoactivated depot (PAD) approach allows for variable and extended release of therapeutic peptides.
- Light-controlled insulin delivery via PAD shows promise for diabetes management.
- This technology supports precise control over insulin dosage and release duration.
More Related Videos
08:04Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
Published on: November 3, 2023
09:07Longitudinal In Vivo Imaging and Quantification of Human Pancreatic Islet Grafting and Contributing Host Cells in the Anterior Eye Chamber
Published on: June 11, 2020
Related Concept Videos
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Insulin Secretory Vesicles
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Insulin: The Receptor and Signaling Pathways